Sun Pharma, India's largest drugmaker, is set to acquire the remaining 21.52% stake in Israel-based Taro Pharmaceutical Industries for ₹2,891.7 crore. This move will allow Sun Pharma to consolidate control over Taro, as it currently owns 78.48% of the company. Sun Pharma had previously faced resistance from Taro's minority shareholders in its bid to take full control.
